David S. Newcombe
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects 10
- Nephrology top 10%
- Gout, Hyperuricemia, Uric Acid 9
- Biochemistry top 10%
- Eicosanoids and Hypertension Pharmacology 3
-
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 3
-
- Biochemical and Molecular Research 6
- Peroxisome Proliferator-Activated Receptors 3
-
- Metabolism and Genetic Disorders 4
-
- Orthopedic Infections and Treatments 3
- Co-authors
- Carl P. CiosekYoshinori IshikawaJohn V. FaheyJoseph ChangAli M. SabooriAlan S. CohenDavid M. LangGlenn A. Warr
- Cited by
- PharmacologyNephrologyBiochemistry
- Partner nations
- United States
In The Last Decade
David S. Newcombe
41 papers receiving 768 citations
Peers
Comparison fields: 5 of 104
- Pharmacology 191
- Nephrology 70
- Biochemistry 70
- Cancer Research 79
- Genetics 54
Countries citing papers authored by David S. Newcombe
This map shows the geographic impact of David S. Newcombe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Newcombe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Newcombe more than expected).
Fields of papers citing papers by David S. Newcombe
This network shows the impact of papers produced by David S. Newcombe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Newcombe. The network helps show where David S. Newcombe may publish in the future.
Co-authorship network
The 22 scholars most cited alongside David S. Newcombe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 36 | |
| 2 | 1991 | 54 | |
| 3 | 1989 | 20 | |
| 4 | 1988 | 14 | |
| 5 | 1988 | 47 | |
| 6 | 1982 | 7 | |
| 7 | 1981 | 46 | |
| 8 | 1978 | 7 | |
| 9 | 1977 | 24 | |
| 10 | Inherited biochemical disorders and uric acid metabolism | 1975 | 5 |
| 11 | 1975 | 59 | |
| 12 | 1974 | 6 | |
| 13 | 1973 | 31 | |
| 14 | 1972 | 16 | |
| 15 | 1972 | 17 | |
| 16 | 1970 | 10 | |
| 17 | 1969 | 3 | |
| 18 | 1968 | 4 | |
| 19 | 1966 | 43 | |
| 20 | 1965 | 20 |
About David S. Newcombe
David S. Newcombe is a scholar working on Nephrology, Pharmacology and Clinical Biochemistry, having authored 41 papers that have together received 879 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (10 papers), Gout, Hyperuricemia, Uric Acid (9 papers), Biochemical and Molecular Research (6 papers), Metabolism and Genetic Disorders (4 papers), Eicosanoids and Hypertension Pharmacology (3 papers), Orthopedic Infections and Treatments (3 papers), Peroxisome Proliferator-Activated Receptors (3 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). The work is most often cited by research in Pharmacology (191 citations), Nephrology (70 citations) and Biochemistry (70 citations). David S. Newcombe has collaborated with scholars based in United States. Frequent co-authors include Carl P. Ciosek, Yoshinori Ishikawa, John V. Fahey, Joseph Chang, Ali M. Saboori, Alan S. Cohen, David M. Lang, Glenn A. Warr, Ahmed H. Esa and Michel Laviolette.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.